🟢 Hims Hers Health Inc is trading 4.1% up today in a rebound following its post-acquisition pullback

Hims Hers Health Inc is trading at $27.27, up 4.1%, as the stock recovers from a 6.5% drop on June 5 following a volatile rally linked to its GLP-1 strategy.

• The price action marks a rebound from a recent pullback that followed a sharp multi-day rally triggered by the company's $1.15 billion acquisition of Eucalyptus.
• The move coincides with a broader lift in U.S. equities, with the S&P 500 and Nasdaq both gaining approximately 1%.
• Market analysts attribute the rise to a combination of company-specific mean reversion and improved risk sentiment across the healthcare and technology sectors.